Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Src homology 2 domain (SH2 domain)** is a structurally conserved protein domain of about 100 amino acids found within many intracellular signal transduction proteins, especially those involved in pathways regulated by tyrosine phosphorylation. SH2 domains specifically bind to short peptide sequences containing phosphorylated tyrosine residues on partner proteins, acting as modules that mediate protein–protein interactions in signal transduction cascades. They play critical roles in cellular processes such as growth, proliferation, immune response, and gene transcription by linking cell surface receptor activation (most notably receptor tyrosine kinases) to downstream intracellular signaling. SH2 domain–containing proteins are implicated in normal physiology as well as disease processes, chiefly various cancers and immunodeficiencies, when signaling fidelity is disrupted[1][2][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Src homology 2 domain (SH2 domain).